Liu Yangli, Tan Weiping, Chen Haihong, Zhu Ying, Wan Li, Jiang Ke, Guo Yubiao, Tang Kejing, Xie Canmao, Yi Hui, Kuang Yukun, Luo Yifeng
Division of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Sun Yat-sen University, Institute of Pulmonary Diseases, Sun Yat-sen University, Guangzhou, 510080, Province Guangdong, People's Republic of China.
Department of Radiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, Province Guangdong, People's Republic of China.
BMC Infect Dis. 2021 Jan 18;21(1):79. doi: 10.1186/s12879-021-05792-7.
The lack of knowledge regarding the pathogenesis and host immune response during SARS-CoV-2 infection has limited the development of effective treatments. Thus, we longitudinally investigated the dynamic changes in peripheral blood lymphocyte subsets and parallel changes in cytokine levels in COVID-19 patients with different disease severities to further address disease pathogenesis.
A total of 67 patients (10 moderate, 38 severe and 19 critical cases) with COVID-19 admitted to a tertiary care hospital in Wuhan from February 8th to April 6th, 2020 were retrospectively studied. Dynamic data of lymphocyte subsets and inflammatory cytokines were collected.
On admission, compared with moderate cases, severe and critical cases showed significantly decreased levels of total lymphocytes, T lymphocytes, CD4 T cells, CD8 T cells, B cells and NK cells. IL-6 and IL-10 were significantly higher in the critical group. During the following hospitalization period, most of the lymphocyte subsets in the critical group began to recover to levels comparable to those in the severe group from the fourth week after illness onset, except for NK cells, which recovered after the sixth week. A sustained decrease in the lymphocyte subsets and an increase in IL-6 and IL-10 were observed in the nonsurvivors until death. There was a strong negative correlation between IL-6 and IL-10 and total lymphocytes, T lymphocytes, CD4 T cells, CD8 T cells and NK cells.
A sustained decrease in lymphocyte subsets, especially CD4 T cells and NK cells, interacting with proinflammatory cytokine storms was associated with severe disease and poor prognosis in COVID-19.
对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染期间发病机制和宿主免疫反应的认识不足,限制了有效治疗方法的开发。因此,我们纵向研究了不同疾病严重程度的新型冠状病毒肺炎(COVID-19)患者外周血淋巴细胞亚群的动态变化以及细胞因子水平的平行变化,以进一步探讨疾病发病机制。
回顾性研究了2020年2月8日至4月6日在武汉一家三级医院收治的67例COVID-19患者(10例中度、38例重度和19例危重症)。收集淋巴细胞亚群和炎性细胞因子的动态数据。
入院时,与中度病例相比,重度和危重症病例的总淋巴细胞、T淋巴细胞、CD4 T细胞、CD8 T细胞、B细胞和自然杀伤(NK)细胞水平显著降低。危重症组白细胞介素6(IL-6)和白细胞介素10(IL-10)显著升高。在随后的住院期间,危重症组的大多数淋巴细胞亚群从发病后第四周开始恢复到与重度组相当的水平,但NK细胞除外,其在第六周后恢复。在非幸存者中,直至死亡,淋巴细胞亚群持续减少,IL-6和IL-10升高。IL-6和IL-10与总淋巴细胞、T淋巴细胞、CD4 T细胞、CD8 T细胞和NK细胞之间存在强烈的负相关。
淋巴细胞亚群持续减少,尤其是CD4 T细胞和NK细胞,与促炎细胞因子风暴相互作用,与COVID-19的严重疾病和不良预后相关。